Rapid Normalization/Stimulation by 1,25- Dihydroxyvitamin D3of Insulin Secretion and Glucose Tolerance in the Vitamin D-Deficient Rat*
- 1 April 1987
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 120 (4) , 1490-1497
- https://doi.org/10.1210/endo-120-4-1490
Abstract
It has been previously demonstrated in this laboratory that vitamin D3 is essential for normal insulin secretion from the perfused rat pancreas. More recently we have shown, consistent with a physiological role for the vitamin in this process, that vitamin D-deficient rats exhibit impaired glucose clearance and insulin secretion, as monitored during iv glucose tolerance tests. Both of these parameters are significantly improved after vitamin D repletion independently of nutritional factors and the prevailing plasma calcium and phosphorus concentrations. In this present study the dose response and time course of effect of a single sc injection of the active metabolite 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] on glucose tolerance and insulin secretion were investigated. The impaired glucose clearance of vitamin D-deficient rats (KG = 912 .+-. 37, where KG is a function of glucose tolerance) was markedly improved as early as 3 h after acute 1,25 (OH)2D3 (1.3 nmol;20 U) administration (KG = 676 .+-. 13), and this clearance was maintained for up to 20 h (KG = 688 .+-. 24). This improvement corresponded to enhanced glucose-induced insulin secretion. By 3 h after 1,25-(OH)2D3 substitution, the peak of insulin secretion was elevated by 170% of control values, independently of a significant increase in plasma phosphorus or plasma calcium concentrations. The hypoglycemic propensity of 1,25-(OH)2D3 was also dose dependent. Glucose tolerance was significant improved (KG = 573 .+-. 33), and insulin secretion was maximal (250% of control) after administration of only 0.26 nmol (4 U) 1,25-(OH)2D3. Higher concentrations of seco-steroid, although stimulatory, proved less effective. This study demonstrates a rapid response (within 3 h) to the potentiating action of 1,25-(OH)2D3 on in vivo insulin secretion and glucose clearance in the vitamin D-deficient rat. A dose dependence of this hypoglycemic action is also established.This publication has 23 references indexed in Scilit:
- EFFECT OF 1.25-DIHYDROXYCHOLECALCIFEROL ADMINISTRATION ON BLOOD GLUCOSE AND PANCREATIC ISLET MORPHOLOGY IN MICEActa Pathologica Microbiologica Scandinavica Section A Pathology, 2009
- IMMUNOCYTOCHEMISTRY OF VITAMIN D-DEPENDENT CALCIUM BINDING PROTEIN IN CHICK PANCREAS: EXCLUSIVE LOCALIZATION IN B-CELLS.*Endocrinology, 1982
- Receptors for 1,25-dihydroxyvitamin D3 in chick pancreas: A partial physical and functional characterizationThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- Studies on the Mode of Action of Calciferol. XXIX.Biochemical Characterization of 1,25-Dihydroxyvitamin D3Receptors in Chick Pancreas and Kidney Cytosol*Endocrinology, 1981
- Target cells for 1,25 dihydroxyvitamin D3 in the pancreasCell and tissue research, 1980
- Studies on the mode of action of calciferol XVIII. Evidence for a specific high affinity binding protein for 1,25 dihydroxyvitamin D3 in chick kidney and pancreasBiochemical and Biophysical Research Communications, 1979
- Studies on the Mode of Action of Calciferol. XIII. Development of a Radioimmunoassay for Vitamin DDependent Chick Intestinal Calcium-Binding Protein and Tissue Distribution*Endocrinology, 1979
- The relative roles of calcium, phosphorus, and parathyroid hormone in glucose- and tolbutamide-mediated insulin release.Journal of Clinical Investigation, 1976
- Effect of fasting upon insulin secretion in the ratAmerican Journal of Physiology-Legacy Content, 1967
- Cation Requirements for Insulin Secretion in the Isolated Perfused PancreasDiabetes, 1966